fcdabcaf

Seth Richards

Contact us by Email

Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.

More From Seth Richards

  • uploads///Acq
    Company & Industry Overviews

    Mylan’s Recent Acquisitions Continue to Strengthen Its Position in International Markets

    Mylan takes an M&A strategy to save time related to compliance activities for obtaining regulatory approvals across various international markets.

    By Seth Richards
  • uploads///API
    Company & Industry Overviews

    How Has Manufacturing Its Own Active Pharmaceutical Ingredients Helped Mylan?

    Mylan is one of largest API (active pharmaceutical ingredient) manufacturers in the world, with nine API and intermediate manufacturing facilities.

    By Seth Richards
  • uploads///Therapeutic Area
    Company & Industry Overviews

    Mylan Product Portfolio across Key Therapeutic Areas

    Mylan is a leading pharmaceutical company that operates in more than 140 countries and operates across five different therapeutic areas.

    By Seth Richards
  • uploads///EpiPen Auto Injector
    Company & Industry Overviews

    Assessing the Role of the EpiPen Auto-Injector in Mylan’s Revenues

    Used to deliver Epinephrine in the treatment of severe allergic reactions, Mylan’s EpiPen auto-injectors hold the number one rank in the epinephrine market.

    By Seth Richards
  • uploads///Business Model
    Company & Industry Overviews

    Mylan’s Business Model: A Key Investor Rundown

    In 2014, Mylan earned about 85% of its total revenues from the US generic market, which is the largest generic market in the world.

    By Seth Richards
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.